本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Candel Therapeutics, Inc.

13.60
+0.74005.75%
盤後13.40-0.2000-1.47%19:30 EDT
成交量:134.29萬
成交額:1,826.75萬
市值:10.41億
市盈率:-9.45
高:13.95
開:13.09
低:12.97
收:12.86
52周最高:13.95
52周最低:4.35
股本:7,651.86萬
流通股本:6,005.68萬
量比:0.96
換手率:2.24%
股息:- -
股息率:- -
每股收益(TTM):-1.4390
每股收益(LYR):-0.7210
淨資產收益率:-81.84%
總資產收益率:-28.64%
市淨率:8.25
市盈率(LYR):-18.86

資料載入中...

2025/03/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/13

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/13

重要事件披露

Form 8-K - Current report
2025/03/13

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/25

重要事件披露

Form 8-K - Current report
2025/01/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/17

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/12/13

重要事件披露

Form 8-K - Current report
2024/12/11

重要事件披露

Form 8-K - Current report